Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 3Uterine Cervical Neoplasms 1Urologic Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasm Metastasis 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Leukemia 1Hepatoblastoma 1Head and Neck Neoplasms 1HER2 Positive Advanced Gastric Cancer 1Endometrial Neoplasms 1Colorectal Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinosarcoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Tissue Banks 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HER2 Positive Advanced Gastric Cancer × Tissue Banks × Gastrointestinal × Clear all
NCT05348161 2022-04-27

Dynamic Multiomics Evaluation of Anti-HER2 and Immunotherapy in HER2 Positive Gastric Cancer

Peking University

Phase NA Unknown
100 enrolled
Gastrointestinal

HER2 Positive Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡